(Q38245642)

31 August 2017

title

The baboon model of pertussis: effective use and lessons for pertussis vaccines (English)

1 reference

31 August 2017

Jason M Warfel

1

1 reference

31 August 2017

Tod J Merkel

series ordinal

2

1 reference

31 August 2017

publication date

3 September 2014

1 reference

Expert Review of Vaccines

31 August 2017

published in

1 reference

31 August 2017

volume

13

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

1241-1252

1 reference

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Update on pertussis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

California pertussis epidemic, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Changing pertussis epidemiology: everything old is new again

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Re-emergence of pertussis: what are the solutions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Priming with whole-cell versus acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Waning protection after fifth dose of acellular pertussis vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Waning immunity to pertussis following 5 doses of DTaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Nonhuman primate and human challenge models of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Resurgence of pertussis calls for re-evaluation of pertussis animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

The benefits of using diverse animal models for studying pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Critical pertussis illness in children: a multicenter prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

RESULTS OF THE INTRATRACHEAL INJECTION OF THE BORDET-GENGOU BACILLUS IN THE MONKEY AND RABBIT

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Nonhuman primate model of pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Airborne transmission of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

IACUC review of nonhuman primate research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

The Baboon (Papio spp.) as a model of human Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Baboon model for West Nile virus infection and vaccine evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Sepsis and pathophysiology of anthrax in a nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

The role of Th17 cytokines in primary mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Interleukin-17 and lung host defense against Klebsiella pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

21 January 2018

The pertussis problem.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Complex correlates of protection after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Possible options for new pertussis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Pertussis: severe clinical presentation in pediatric intensive care and its relation to outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Fatal pulmonary hypertension associated with pertussis in infants: does extracorporeal membrane oxygenation have a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Pathology and pathogenesis of fatal Bordetella pertussis infection in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Infant pertussis: who was the source?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Prospective Multinational Study of Pertussis Infection in Hospitalized Infants and Their Household Contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Immunogenicity of a three-component acellular pertussis vaccine administered at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Effect of a Prepregnancy Pertussis Booster Dose on Maternal Antibody Titers in Young Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Pertussis pathogenesis--what we know and what we don't know

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Bordetella pertussis pathogenesis: current and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Pertactin-negative variants of Bordetella pertussis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Studies on Prn variation in the mouse model and comparison with epidemiological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.946016

10.1586/14760584.2014.946016

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference